The mutations of the B-Raf proto-oncogene serine/threonine-kinase (BRAF), NRAS, and tumor protein p53 (TP53) are the main mutations that account for approximately 75% of all melanomas used for MM classification7–9. The gene discussed is BRAF; the disease is melanoma.